Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain...

Area of Science:

• Oncology
• Vascular Biology
• Cancer Therapeutics

Background:

• Solid tumor growth and metastasis depend on the formation of new blood vessels via angiogenesis.
• Brain tumors exhibit significant angiogenesis, making them susceptible to antiangiogenic strategies.
• Antiangiogenic therapy is a promising approach for managing brain tumors, particularly when combined with other treatments.

Purpose of the Study:

• To review the fundamental characteristics of brain tumor angiogenesis.
• To identify angiogenic factors that can be targeted for therapy.
• To discuss the current status, mechanisms, and limitations of antiangiogenic therapy for brain tumors.

Main Methods:

• Literature review of preclinical and clinical studies on brain tumor angiogenesis and antiangiogenic therapy.
• Analysis of the role of angiogenic factors in brain tumor development.
• Evaluation of the efficacy and mechanisms of current antiangiogenic treatments.

Main Results:

• Brain tumor angiogenesis is a critical factor in tumor progression.
• Several angiogenic factors have been identified as potential therapeutic targets.
• Antiangiogenic therapy demonstrates potential in controlling brain tumors, with ongoing research into its mechanisms and limitations.

Conclusions:

• Targeting angiogenesis is a viable strategy for brain tumor treatment.
• Further research is needed to optimize antiangiogenic therapies and overcome resistance.
• Combination therapies hold significant promise for improving patient outcomes in brain tumor management.